AQST - Aquestive Therapeutics Inc. (AQST) CEO Keith Kendall on Q4 2019 Results - Earnings Call Transcript
Aquestive Therapeutics, Inc. (AQST)
Q4 2019 Earnings Conference Call
March 12, 2020 8:00 AM ET
Company Participants
Stephanie Carrington - Westwicke Investor Relations
Keith Kendall - Chief Executive Officer
John Maxwell - Chief Financial Officer
Conference Call Participants
Gary Nachman - BMO Capital Markets
Dan Busby - RBC Capital Markets
Roy Buchanan - JMP Securities
Liana Moussatos - Wedbush Securities
Thomas Flaten - Lake Street Capital Markets
Edward White - H.C. Wainwright
Presentation
Operator
Good morning and welcome to the Aquestive Therapeutics Fourth Quarter and Full Year 2019 Conference Call. At this time, all participants